Dementia- Alzheimer’s Research Papers November 2000

Dementia- Alzheimer’s Research Papers November 2000

           

Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13045-50.

Gamblin TC, King ME, Kuret J, Berry RW, Binder LI. Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry. 2000 Nov 21;39(46):14203-10.

Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett. 2000 Nov 17;485(1):87-93.

Ogawa O, Umegaki H, Sumi D, Hayashi T, Nakamura A, Thakur NK, Yoshimura J, Endo H, Iguchi A. Inhibition of inducible nitric oxide synthase gene expression by indomethacin or ibuprofen in beta-amyloid protein-stimulated J774 cells. Eur J Pharmacol. 2000 Nov 17;408(2):137-41.

Helmuth L. Neuroscience. An antibiotic to treat Alzheimer's? Science. 2000 Nov 17;290(5495):1273-4.

Huang TH, Yang DS, Fraser PE, Chakrabartty A. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid. J Biol Chem. 2000 Nov 17;275(46):36436-40.

Zill P, Bürger K, Behrens S, Hampel H, Padberg F, Boetsch T, Möller HJ, Ackenheil M, Bondy B. Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients. Neurosci Lett. 2000 Nov 17;294(2):69-72. , ,

Hock C, Wettstein A, Giannakopoulos P, Schüpbach B, Müller-Spahn F. [Diagnosis and therapy of behavior disorders in dementia] Schweiz Rundsch Med Prax. 2000 Nov 16;89(46):1907-13.

Reiss C, Lesnik T, Parvez H, Parvez S, Ehrlich R. Conformational toxicity and sporadic conformational diseases. Toxicology. 2000 Nov 16;153(1-3):115-21.

Oshiro S, Kawahara M, Kuroda Y, Zhang C, Cai Y, Kitajima S, Shirao M. Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells. Biochim Biophys Acta. 2000 Nov 15;1502(3):405-14.

Gibson GE, Zhang H, Sheu KR, Park LC. Differential alterations in antioxidant capacity in cells from Alzheimer patients. Biochim Biophys Acta. 2000 Nov 15;1502(3):319-29.

Neely MD, Zimmerman L, Picklo MJ, Ou JJ, Morales CR, Montine KS, Amaranth V, Montine TJ. Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Free Radic Biol Med. 2000 Nov 15;29(10):1028-36.

Kopan R, Goate A. A common enzyme connects notch signaling and Alzheimer's disease. Genes Dev. 2000 Nov 15;14(22):2799-806.

Hashimoto Y, Jiang H, Niikura T, Ito Y, Hagiwara A, Umezawa K, Abe Y, Murayama Y, Nishimoto I. Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases. J Neurosci. 2000 Nov 15;20(22):8401-9.

Zhang Y, Goodyer C, LeBlanc A. Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. J Neurosci. 2000 Nov 15;20(22):8384-9.

Noll E, Medina M, Hartley D, Zhou J, Perrimon N, Kosik KS. Presenilin affects arm/beta-catenin localization and function in Drosophila. Dev Biol. 2000 Nov 15;227(2):450-64.

Yamauchi K, Tozuka M, Hidaka H, Nakabayashi T, Sugano M, Kondo Y, Nakagawara A, Katsuyama T. Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells. J Neurosci Res. 2000 Nov 15;62(4):608-14.

Barger SW, Chavis JA, Drew PD. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J Neurosci Res. 2000 Nov 15;62(4):503-9.

  

Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J, Tycko R. Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry. 2000 Nov 14;39(45):13748-59.

Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology. 2000 Nov 14;55(9):1278-83.

Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, Schafer K, Thal LJ, Alzheimer's Disease Cooperative Study. Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology. 2000 Nov 14;55(9):1271-8.

 

Mah AL, Perry G, Smith MA, Monteiro MJ. Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol. 2000 Nov 13;151(4):847-62.

 

  

Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet. 2000 Nov 11;356(9242):1627-31.

 

Hu M, Retz W, Baader M, Pesold B, Adler G, Henn FA, Rösler M, Thome J. Promoter polymorphism of the 5-HT transporter and Alzheimer's disease. Neurosci Lett. 2000 Nov 10;294(1):63-5. , ,

Harris JM, Cumming AM, Craddock N, St Clair D, Lendon CL. Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population. Neurosci Lett. 2000 Nov 10;294(1):37-40. ,

Lau KF, McLoughlin DM, Standen CL, Irving NG, Miller CC. Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein. Neuroreport. 2000 Nov 9;11(16):3607-10.

 

Halimi G, Duplan L, Bideau C, Iniesta D, Berthézène P, Oddoze C, Verdier JM, Michel B, Bergé-Lefranc JL. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease. Neuroreport. 2000 Nov 9;11(16):3599-601. ,

Dringenberg HC, Laporte PP, Diavolitsis P. Increased effectiveness of tacrine by deprenyl co-treatment in rats: EEG and behavioral evidence. Neuroreport. 2000 Nov 9;11(16):3513-6.

Macdonald NJ, Taglialatela G. Tumor necrosis factor-alpha and nerve growth factor synergistically induce iNOS in pheochromocytoma cells. Neuroreport. 2000 Nov 9;11(16):3453-6.

Grilli M, Diodato E, Lozza G, Brusa R, Casarini M, Uberti D, Rozmahel R, Westaway D, St George-Hyslop P, Memo M, Ongini E. Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12822-7.

 

Sobel RK. Alzheimer's first blow. Head injuries raise risk. US News World Rep. 2000 Nov 6;129(18):54.

Sohrabji F, Peeples KW, Marroquin OA. Local and cortical effects of olfactory bulb lesions on trophic support and cholinergic function and their modulation by estrogen. J Neurobiol. 2000 Nov 5;45(2):61-74.

Liang JJ. Interaction between beta-amyloid and lens alphaB-crystallin. FEBS Lett. 2000 Nov 3;484(2):98-101.

Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000 Nov 3;290(5493):985-9.

 

Seiffert D, Bradley JD, Rominger CM, Rominger DH, Yang F, Meredith JE, Wang Q, Roach AH, Thompson LA, Spitz SM, Higaki JN, Prakash SR, Combs AP, Copeland RA, Arneric SP, Hartig PR, Robertson DW, Cordell B, Stern AM, Olson RE, Zaczek R. Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J Biol Chem. 2000 Nov 3;275(44):34086-91.

Hashimoto Y, Niikura T, Ito Y, Nishimoto I. Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. J Biol Chem. 2000 Nov 3;275(44):34541-51.

Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY, Botas J. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 2000 Nov 2;408(6808):101-6.

 

Hurko O, Walsh FS. Novel drug development for amyotrophic lateral sclerosis. J Neurol Sci. 2000 Nov 1;180(1-2):21-8.

Hussain I, Powell DJ, Howlett DR, Chapman GA, Gilmour L, Murdock PR, Tew DG, Meek TD, Chapman C, Schneider K, Ratcliffe SJ, Tattersall D, Testa TT, Southan C, Ryan DM, Simmons DL, Walsh FS, Dingwall C, Christie G. ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol Cell Neurosci. 2000 Nov;16(5):609-19.

 

Minster RL, DeKosky ST, Ganguli M, Belle S, Kamboh MI. Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann Neurol. 2000 Nov;48(5):817-9. ,

  

Praticò D, Clark CM, Lee VM, Trojanowski JQ, Rokach J, FitzGerald GA. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann Neurol. 2000 Nov 1;48(5):809-12. ,

Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, Wood NW, Kumar-Singh S, Geddes J, Swash M, Scaravilli F, Holton JL, Lashley T, Tomita T, Hashimoto T, Verkkoniemi A, Kalimo H, Somer M, Paetau A, Martin JJ, Van Broeckhoven C, Golde T, Hardy J, Haltia M, Revesz T. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol. 2000 Nov;48(5):806-8.

Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, Coleman RE. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med. 2000 Nov;41(11):1920-8.

Marsh GW, Prochoda KP, Pritchett E, Vojir CP. Predicting hospice appropriateness for patients with dementia of the Alzheimer's type. Appl Nurs Res. 2000 Nov;13(4):187-96.

Zemaitaitis MO, Lee JM, Troncoso JC, Muma NA. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. J Neuropathol Exp Neurol. 2000 Nov;59(11):983-9.

Chin JY, Knowles RB, Schneider A, Drewes G, Mandelkow EM, Hyman BT. Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study. J Neuropathol Exp Neurol. 2000 Nov;59(11):966-71.

Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, Chui HC. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000 Nov;59(11):931-45.

Chang P, Su Y. Protocol for quantitative and qualitative analyses of the in vitro aggregation of synthetic beta-amyloid. A method applicable to the identification of substances that may have therapeutic efficacy for Alzheimer's disease. Brain Res Brain Res Protoc. 2000 Nov;6(1-2):6-12.

Broe GA, Grayson DA, Creasey HM, Waite LM, Casey BJ, Bennett HP, Brooks WS, Halliday GM. Anti-inflammatory drugs protect against Alzheimer disease at low doses. Arch Neurol. 2000 Nov;57(11):1586-91.

 

Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR, Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH, Nitsch RM. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol. 2000 Nov;57(11):1579-83. , ,

Bedlack RS, Strittmatter WJ, Morgenlander JC. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol. 2000 Nov;57(11):1561-5.

Howlett DR, Simmons DL, Dingwall C, Christie G. In search of an enzyme: the beta-secretase of Alzheimer's disease is an aspartic proteinase. Trends Neurosci. 2000 Nov;23(11):565-70.

Tesseur I, Van Dorpe J, Bruynseels K, Bronfman F, Sciot R, Van Lommel A, Van Leuven F. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am J Pathol. 2000 Nov 1;157(5):1495-510.

Brunello AG, Weissenberger J, Kappeler A, Vallan C, Peters M, Rose-John S, Weis J. Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice. Am J Pathol. 2000 Nov;157(5):1485-93.

Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VM, Trojanowski JQ. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol. 2000 Nov;157(5):1439-45.

Gwyther LP. Family issues in dementia: finding a new normal. Neurol Clin. 2000 Nov;18(4):993-1010.

Rosen HJ, Lengenfelder J, Miller B. Frontotemporal dementia. Neurol Clin. 2000 Nov;18(4):979-92.

Selkoe DJ. The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins. Neurol Clin. 2000 Nov;18(4):903-22.

 

Perl DP. Neuropathology of Alzheimer's disease and related disorders. Neurol Clin. 2000 Nov;18(4):847-64.

Chung JA, Cummings JL. Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment. Neurol Clin. 2000 Nov;18(4):829-46.

Grundman M, Thal LJ. Treatment of Alzheimer's disease: rationale and strategies. Neurol Clin. 2000 Nov;18(4):807-28.

Petersen RC. Aging, mild cognitive impairment, and Alzheimer's disease. Neurol Clin. 2000 Nov;18(4):789-806.

Balestrieri M, Nacmias B, Sorbi S, Marcon G. Are premorbid personality traits linked to the risk of Alzheimer's Disease? A case series of subjects with familial mutation. Psychother Psychosom. 2000 Nov-Dec;69(6):335-8.

Meda C, Vegeto E, Pollio G, Ciana P, Patrone C, Pellicciari C, Maggi A. Oestrogen prevention of neural cell death correlates with decreased expression of mRNA for the pro-apoptotic protein nip-2. J Neuroendocrinol. 2000 Nov;12(11):1051-9.

Huang C, Wahlund L, Dierks T, Julin P, Winblad B, Jelic V. Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol. 2000 Nov;111(11):1961-7.

Diamandis EP, Yousef GM, Petraki C, Soosaipillai AR. Human kallikrein 6 as a biomarker of alzheimer's disease. Clin Biochem. 2000 Nov;33(8):663-7. ,

Ishii K, Sasaki M, Matsui M, Sakamoto S, Yamaji S, Hayashi N, Mori T, Kitagaki H, Hirono N, Mori E. A diagnostic method for suspected Alzheimer's disease using H(2)15O positron emission tomography perfusion Z score. Neuroradiology. 2000 Nov;42(11):787-94.

Yamada K, Nabeshima T. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther. 2000 Nov;88(2):93-113.

Esposito G, Viglino P, Novak M, Cattaneo A. The solution structure of the C-terminal segment of tau protein. J Pept Sci. 2000 Nov;6(11):550-9.

Haupt M, Siebel U, Palm B, Kretschmar JH, Jänner M. [Effects of family-centered group therapy with demented patients and their caregivers] Fortschr Neurol Psychiatr. 2000 Nov;68(11):503-15.

Kawahara M, Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull. 2000 Nov 1;53(4):389-97.

Moretti R, Torre P, Antonello RM, Cazzato G. Ten-Point Clock test: a correlation analysis with mini-mental state and proverb interpretation score in Alzheimer's disease. Eur J Neurol. 2000 Nov;7(6):746.

Neely , Swift LL, Montine T. Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules. Lipids. 2000 Nov;35(11):1249-57.

Brod SA. Unregulated inflammation shortens human functional longevity. Inflamm Res. 2000 Nov;49(11):561-70.

Knopman DS. Part VII. Treatment of Neuropsychiatric symptoms in Alzheimer's disease. Dis Mon. 2000 Nov;46(11):761-6.

Knopman DS. Part VI. Primary drug therapies for Alzheimer's disease. Dis Mon. 2000 Nov;46(11):745-60.

Galasko DR. Part V. Genetic advances and biological markers for Alzheimer's disease. Dis Mon. 2000 Nov;46(11):731-43.

Kim SH, Vlkolinsky R, Cairns N, Lubec G. Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome. Cell Mol Life Sci. 2000 Nov;57(12):1810-6.

Shringarpure R, Grune T, Sitte N, Davies KJ. 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease. Cell Mol Life Sci. 2000 Nov;57(12):1802-9.

Scott LJ, Goa KL. Galantamine: a review of its use in Alzheimer's disease. Drugs. 2000 Nov;60(5):1095-122.

Yao PJ, Weimer JM, O'Herron TM, Coleman PD. Clathrin assembly protein AP-2 is detected in both neurons and glia, and its reduction is prominent in layer II of frontal cortex in Alzheimer's disease. Neurobiol Aging. 2000 Nov-Dec;21(6):921-9.

Arnold SE, Han LY, Clark CM, Grossman M, Trojanowski JQ. Quantitative neurohistological features of frontotemporal degeneration. Neurobiol Aging. 2000 Nov-Dec;21(6):913-9.

Iqbal K, Grundke-Iqbal I. Alzheimer disease is multifactorial and heterogeneous. Neurobiol Aging. 2000 Nov-Dec;21(6):901-2; discussion 903-4.

van Leeuwen FW, Fischer DF, Kamel D, Sluijs JA, Sonnemans MA, Benne R, Swaab DF, Salehi A, Hol EM. Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiol Aging. 2000 Nov-Dec;21(6):879-91.

Gandy S. Alzheimer mice on the couch. Neurobiol Aging. 2000 Nov-Dec;21(6):873; discussion 875-7.

Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging. 2000 Nov-Dec;21(6):845-61.

Khachaturian ZS. Neurobiology of aging: Alzheimer's clinical review series. Bridging bench to bedside: clinical problems in search of basic solution. Neurobiol Aging. 2000 Nov-Dec;21(6):843.

Harris PL, Zhu X, Pamies C, Rottkamp CA, Ghanbari HA, McShea A, Feng Y, Ferris DK, Smith MA. Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. Neurobiol Aging. 2000 Nov-Dec;21(6):837-41.

 

Janicki SM, Stabler SM, Monteiro MJ. Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiol Aging. 2000 Nov-Dec;21(6):829-36.

Husseman JW, Nochlin D, Vincent I. Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging. 2000 Nov-Dec;21(6):815-28.

Zhu X, Rottkamp CA, Raina AK, Brewer GJ, Ghanbari HA, Boux H, Smith MA. Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol Aging. 2000 Nov-Dec;21(6):807-13.

Wu Q, Combs C, Cannady SB, Geldmacher DS, Herrup K. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiol Aging. 2000 Nov-Dec;21(6):797-806.

Arendt T. Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol Aging. 2000 Nov-Dec;21(6):783-96.

Nagy Z. Cell cycle regulatory failure in neurones: causes and consequences. Neurobiol Aging. 2000 Nov-Dec;21(6):761-9.

Holzer C, Warshaw G. Clues to early Alzheimer dementia in the outpatient setting. Arch Fam Med. 2000 Nov-Dec;9(10):1066-70.

Freychet P. Insulin receptors and insulin actions in the nervous system. Diabetes Metab Res Rev. 2000 Nov-Dec;16(6):390-2.

Haas HL, Selbach O. Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):375-81.

Rombouts SA, Barkhof F, Veltman DJ, Machielsen WC, Witter MP, Bierlaagh MA, Lazeron RH, Valk J, Scheltens P. Functional MR imaging in Alzheimer's disease during memory encoding. AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1869-75.

Bigler ED, Lowry CM, Anderson CV, Johnson SC, Terry J, Steed M. Dementia, quantitative neuroimaging, and apolipoprotein E genotype. AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1857-68.

Stahl SM. The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action. J Clin Psychiatry. 2000 Nov;61(11):813-4.

Paulsen JS, Ready RE, Stout JC, Salmon DP, Thal LJ, Grant I, Jeste DV. Neurobehaviors and psychotic symptoms in Alzheimer's disease. J Int Neuropsychol Soc. 2000 Nov;6(7):815-20.

Mahoney DM. Developing technology applications for intervention research: a case study. Comput Nurs. 2000 Nov-Dec;18(6):260-4.

Ksiezak-Reding H, He D, Gordon-Krajcer W, Kress Y, Lee S, Dickson DW. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes. Cell Motil Cytoskeleton. 2000 Nov;47(3):236-52.

Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. J Neurosci Res. 2000 Nov 1;62(3):463-72.

Castillo GM, Lukito W, Peskind E, Raskind M, Kirschner DA, Yee AG, Snow AD. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain. J Neurosci Res. 2000 Nov 1;62(3):451-62.

Farber SA, Slack BE, Blusztajn JK. Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease. FASEB J. 2000 Nov;14(14):2198-206.

Jeong SJ, Kim HS, Chang KA, Geum DH, Park CH, Seo JH, Rah JC, Lee JH, Choi SH, Lee SG, Kim K, Suh YH. Subcellular localization of presenilins during mouse preimplantation development. FASEB J. 2000 Nov;14(14):2171-6.

Alreja M, Wu M, Liu W, Atkins JB, Leranth C, Shanabrough M. Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: implications for learning and memory. J Neurosci. 2000 Nov 1;20(21):8103-10.

Buccafusco JJ, Terry AV. Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. J Pharmacol Exp Ther. 2000 Nov;295(2):438-46.

Tarkowski E, Ringqvist A, Blennow K, Wallin A, Wennmalm A. Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):322-6.

Querfurth HW, Allam GJ, Geffroy MA, Schiff HB, Kaplan RF. Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial. Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):314-21.

Irizarry MC, Cheung BS, Rebeck GW, Paul SM, Bales KR, Hyman BT. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice. Acta Neuropathol. 2000 Nov;100(5):451-8.

Dharmarajan TS, Narayanan SL, Ali R, Ahmed S. Appropriateness of laboratory testing in nursing home elderly with advanced dementia: an opinion poll among physicians. J Am Med Dir Assoc. 2000 Nov-Dec;1(6):279-81.

Small GW, Tariot PN, Katz PR. Teamwork in Alzheimer's disease: the interdisciplinary approach to treatment. J Am Med Dir Assoc. 2000 Nov-Dec;1(6 Suppl):S11-4.

Botting J. Defining the role of COX-2 inhibitors in inflammatory and other diseases. Drug News Perspect. 2000 Nov;13(9):560-6.

Razani J, Boone K. Cognitive patterns of left- and right-frontotemporal dementia compared to Alzheimer's disease. Arch Clin Neuropsychol. 2000 Nov;15(8):749.

Freeman RQ. Intrusion errors in learning and memory: a comparison of Alzheimer's disease and vascular dementia. Arch Clin Neuropsychol. 2000 Nov;15(8):748-9.

Levinson D, Watson J, Reeves D, Harrison M. Computerized neuropsychological (ANAM) measures of cognitive effects of alzheimer's disease. Arch Clin Neuropsychol. 2000 Nov;15(8):739-40.

Cruzen MJ, Lacritz LH, Chapman SB, Silver C, Weiner M, Cullum CM. Verbal and visuospatial subtypes in Alzheimer's disease: how different are they? Arch Clin Neuropsychol. 2000 Nov;15(8):730-1.

Acevedo A, Loewenstein DA, Ownby R, Schram L. Factor structure of neuropsychological test performance of English- and Spanish speaking patients with Alzheimer's disease. Arch Clin Neuropsychol. 2000 Nov;15(8):750.

Loewenstein DA, Acevedo A, Ownby R, Schram L. The NINCDS-ADRDA neuropsychological criteria for Alzheimer's disease: a confirmatory factor analysis of single versus multi-factor models. Arch Clin Neuropsychol. 2000 Nov;15(8):747.

Schram L, Loewenstein D, Acevedo A, Freeman R, Mendelson E. Characteristics of digit span in Alzheimer's disease patients. Arch Clin Neuropsychol. 2000 Nov;15(8):746-7.

Matheny J, Dickson AL, Gierok SD, Schiehser D. Uncued and cued category fluency in elderly alzheimer's patients and normal elderly. Arch Clin Neuropsychol. 2000 Nov;15(8):738.

Gomez RG, Storandt M, White D. The diagnostic contribution of Animal Fluency in detecting older adults with very mild dementia of the Alzheimer type. Arch Clin Neuropsychol. 2000 Nov;15(8):730.

Jurik J, Donnelly JF, Kramer JK, Miller BL. Differentiation between frontotemporal dementia and Alzheimer's disease using a brief neuropsychological screening battery. Arch Clin Neuropsychol. 2000 Nov;15(8):708-9.

Donnelly JF, Jurik J, Kramer JK, Miller BL. Rate of forgetting, intrusions and recognition in Alzheimer's and frontotemporal dementia as indexed by the CVLT-Short Form. Arch Clin Neuropsychol. 2000 Nov;15(8):708.

Batchelor ES. Alzheimer's disease masked as steroid induced dementia. Arch Clin Neuropsychol. 2000 Nov;15(8):849-50.

Ownby RL. ROC curve analyses of neuropsychological tests in Alzheimer's disease. Arch Clin Neuropsychol. 2000 Nov;15(8):748.

Andrikopoulos J. Neuropsychological functioning and depression in Alzheimer's Disease. Arch Clin Neuropsychol. 2000 Nov;15(8):738-9.

Duff K, McCaffrey RJ, Solomon GS. Olfactory functioning in Alzheimer's disease, vascular dementia, and major depression. Arch Clin Neuropsychol. 2000 Nov;15(8):709.

Papassotiropoulos A, Bagli M, Becker K, Jessen F, Maier W, Rao ML, Ludwig M, Heun R. No association between an intronic biallelic polymorphism of the FE65 gene and Alzheimer's disease. Int J Mol Med. 2000 Nov 1;6(5):587-9. ,

Pittiglio L. Use of reminiscence therapy in patients with Alzheimer's disease. Lippincotts Case Manag. 2000 Nov-Dec;5(6):216-20.

Sáez-Valero J, Barquero MS, Marcos A, McLean CA, Small DH. Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):664-7. ,

Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, Kuret J, Binder LI. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci. 2000 Nov 1;113 Pt 21:3737-45.

Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L. Does APO epsilon4 correlate with MRI changes in Alzheimer's disease? J Neurol Neurosurg Psychiatry. 2000 Nov 1;69(5):668-71. ,

Martire LM, Hall M. Dementia caregiving: recent research on negative health effects and the efficacy of caregiver interventions. CNS Spectr. 2000 Nov;7(11):791-6.

Connolly DM, Pedlar D, MacKnight C, Lewis C, Fisher J. Guidelines for stage-based supports in Alzheimer's care: the FAST-ACT. Functional Assessment Staging Tool-Action Checklist. J Gerontol Nurs. 2000 Nov;26(11):34-45.

De La Monte SM, Ganju N, Feroz N, Luong T, Banerjee K, Cannon J, Wands JR. Oxygen Free Radical Injury Is Sufficient to Cause Some Alzheimer-Type Molecular Abnormalities in Human CNS Neuronal Cells. J Alzheimers Dis. 2000 Nov;2(3,4):261-281.

Sabbagh MN, Galasko D, Koo E, Thal LJ. Amyloid-beta and Treatment Opportunities for Alzheimer's Disease. J Alzheimers Dis. 2000 Nov;2(3,4):231-259.

Cruz-Sánchez FF, Durany N, Thome J, Riederer P, Zambón D. Correlation between Apolipoprotein-E Polymorphism and Alzheimer's Disease Pathology. J Alzheimers Dis. 2000 Nov;2(3,4):223-229.

Grant SM, Ducatenzeiler A, Szyf M, Cuello AC. Abeta Immunoreactive Material Is Present in Several Intracellular Compartments in Transfected, Neuronally Differentiated, P19 Cells Expressing the Human Amyloid beta-Protein Precursor. J Alzheimers Dis. 2000 Nov;2(3,4):207-222.

Hesse C, Rosengren L, Vanmechelen E, Vanderstichele H, Jensen C, Davidsson P, Blennow K. Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke. J Alzheimers Dis. 2000 Nov;2(3,4):199-206. ,

Lerner AJ, Elston RC, Chen CH, Friedland RP. Response of the Hypothalamic-Pituitary-Adrenal Axis to Lumbar Puncture Induced Stress. J Alzheimers Dis. 2000 Nov;2(3,4):193-198.

Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest. 2000 Nov;106(9):1159-66.

Ulery PG, Strickland DK. LRP in Alzheimer's disease: friend or foe? J Clin Invest. 2000 Nov;106(9):1077-9.

Praticò D, Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med. 2000 Nov;109(7):577-85.

Kumar-Singh S, de Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, De Strooper B, Vanderstichele H, Löfgren A, Vanderhoeven I, Backhovens H, Vanmechelen E, Kroisel PM, van Broeckhoven C. Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease. Hum Mol Genet. 2000 Nov 1;9(18):2589-98.

Nishimura A, Ikemoto K, Satoh K, Yamamoto Y, Rand S, Brinkmann B, Nishi K. The carbohydrate deposits detected by histochemical methods in the molecular layer of the dentate gyrus in the hippocampal formation of patients with schizophrenia, Down's syndrome and dementia, and aged person. Glycoconj J. 2000 Nov;17(11):815-22.

Paradowski B, Szczepaniak M, Dobosz T, Sasiadek M. [Apolipoprotein E(ApoE)and tau protein in Alzheimer type dementia] Pol Merkuriusz Lek. 2000 Nov;9(53):758-9.

Yermakova A, O'Banion MK. Cyclooxygenases in the central nervous system: implications for treatment of neurological disorders. Curr Pharm Des. 2000 Nov;6(17):1755-76.

Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000 Nov 1;1(2):120-9.

Pereira C, Agostinho P, Oliveira CR. Vinpocetine attenuates the metabolic dysfunction induced by amyloid beta-peptides in PC12 cells. Free Radic Res. 2000 Nov;33(5):497-506.

Macdonald NJ, Decorti F, Pappas TC, Taglialatela G. Cytokine/neurotrophin interaction in the aged central nervous system. J Anat. 2000 Nov;197 Pt 4:543-51.

Rodrigues CM, Solá S, Silva R, Brites D. Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol Med. 2000 Nov;6(11):936-46.

  

Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 2000 Nov 1;28(2):449-59.

Mooser V. [Lipoprotein (a) in Alzheimer's atherosclerosis] Rev Med Suisse Romande. 2000 Nov;120(11):903-6.

Joray S, Pertoldi W, Büla C. [Detection of cognitive disorders in clinical practice] Rev Med Suisse Romande. 2000 Nov;120(11):847-52.

Navarrete E, Prospéro O, Hudson R, Guevara R. [Neurovegetative diseases in dementia] Gac Med Mex. 2000 Nov-Dec;136(6):573-84.

Chan HY, Bonini NM. Drosophila models of human neurodegenerative disease. Cell Death Differ. 2000 Nov;7(11):1075-80.

Dorta-Contreras AJ, Barshatzky M, Noris-García E, Serrano-Sánchez T. [Transthyretin levels in serum and cerebrospinal fluid sustain the nutrio-viral hypothesis of the Cuban epidemic neuropathy] Rev Neurol. 2000 Nov 1-15;31(9):801-4.

Chan HY, Bonini . Drosophila models of human neurodegenerative disease. Cell Death Differ. 2000 Nov;7(11):1075-80. Abstract

Passer B, Pellegrini L, Russo C, Siegel RM, Lenardo MJ, Schettini G, Bachmann M, Tabaton M, D'Adamio L. Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J Alzheimers Dis. 2000 Nov;2(3-4):289-301.

Cohen RM, Carson RE, Sunderland T. Opiate receptor avidity in the thalamus is sexually dimorphic in the elderly. Synapse. 2000 Nov;38(2):226-9.

Hanyu H, Asano T, Kogure D, Sakurai H, Iwamoto T, Takasaki M. [Relation between hippocampal damage and cerebral cortical function in Alzheimer's disease] Nippon Ronen Igakkai Zasshi. 2000 Nov;37(11):921-7.

Blain H, Jouzeau JY, Netter P, Jeandel C. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects] Rev Med Interne. 2000 Nov;21(11):978-88.

Takahashi M, Doré S, Ferris CD, Tomita T, Sawa A, Wolosker H, Borchelt DR, Iwatsubo T, Kim SH, Thinakaran G, Sisodia SS, Snyder SH. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron. 2000 Nov;28(2):461-73.

Iwata N, Kozuka M, Hara T, Kanek T, Tonohiro T, Sugimoto M, Niitsu Y, Kondo Y, Yamamoto T, Sakai J, Nagano M. Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies. Jpn J Pharmacol. 2000 Nov;84(3):266-80.